Integrated IND Platform
At Davos, we offer an all-encompassing program to develop your company’s lead asset. Our Integrated
IND platform seamlessly integrates all aspects of drug development, including toxicology, pharmacology,
drug substance, and drug product, providing a cohesive approach to your project’s success.
Highlights of the platform:
- We take pride in our unbiased and “program-centric” approach to assembling contractors and the development team.
- Our team is selected based on their professional experience and the developmental needs specific to your asset.
- The typical team includes a program manager, project manager, regulatory affairs expert, QA/QC, toxicology and pharmacology experts, and a clinician.
-
Our Integrated IND platform maximizes the added value of working with Davos.
-
We have established strategic relationships with over 100 global service providers over the past 50 years.
-
All our partners are audited and have an excellent regulatory history. Our relationships ensure rapid execution of developmental activities and seamless collaboration.
- We also provide additional services for our Integrated IND program, such as global shipping and logistics, stability and CoA tracking for all API and drug product batches, onsite audits, accounting accruals as needed by the Sponsor for the SEC (if publicly traded), technical assistance and logistics for
external diligence evaluations for the sale of the Sponsor’s asset, and general and/or product liability insurance for all materials and products.
Whether you require CMC management or a full developmental program for your asset, Davos can help. Contact us today to learn more about our Integrated IND platform and how we can assist you in bringing your lead asset to market.